Ticagrelor Tablets 60 Mg

Ticagrelor Tablets 60 Mg – Advanced Antiplatelet Therapy for Cardiovascular Protection

Ticagrelor Tablets 60 Mg is a prescription cardiovascular medication used to reduce the risk of major thrombotic events in adult patients with acute coronary syndrome (ACS) or a history of myocardial infarction (heart attack). It belongs to a class of drugs called antiplatelet agents, which help prevent the formation of harmful blood clots inside arteries.

Blood clots can block blood flow to the heart or brain and lead to serious cardiovascular events such as heart attack or stroke. Antiplatelet therapy, particularly with ticagrelor, is a critical component of secondary prevention in patients at heightened risk of thrombotic complications.

Evidence-based clinical guidelines support the use of ticagrelor in appropriate patients to prevent clot formation and reduce mortality after acute cardiovascular events.

How Ticagrelor Tablets 60 Mg Work

Ticagrelor Tablets 60 Mg work by inhibiting platelet activation and aggregation:

1. Blocks P2Y12 Receptors

Ticagrelor directly and reversibly binds to the P2Y12 receptor on platelets, preventing adenosine diphosphate (ADP)–mediated platelet activation.

2. Reduces Clot Formation

By preventing platelets from clumping, ticagrelor decreases the likelihood of harmful clot formation in arteries.

3. Rapid Onset of Action

Ticagrelor has a faster onset than some older antiplatelet agents, making it effective soon after dosing.

4. Improved Secondary Prevention

Clinical studies show lower rates of cardiovascular death and recurrent events in eligible patients compared with some alternative therapies.

Indications

Ticagrelor Tablets 60 Mg may be prescribed for:

• Reduction of thrombotic cardiovascular events in adults with a history of myocardial infarction

• Secondary prevention of heart attack and related complications

• As part of dual antiplatelet therapy in appropriate patients

Use only under professional medical supervision, with dosing individualized according to clinical guidelines.

Sustained-release metabolic cardiac care models may include Trimetazidine SR Tablets 60 Mg within long-term cardiovascular management.

Dosage & Administration

• Typically taken twice daily

• Swallow with water and take consistently at the same times each day

• May be taken with or without food

• Follow your doctor’s exact instructions

• Do not stop medication without medical advice

Consistent dosing and adherence to medical guidance are key to optimal outcomes.

Chronic angina management frameworks may integrate Trimetazidine HCl Tablets 20 Mg as part of supervised cardiovascular therapy.

Safety Information & Precautions

Before starting Ticagrelor Tablets 60 Mg, inform your healthcare provider if you have:

• Active bleeding or bleeding disorders

• Recent surgery

• History of stroke or intracranial hemorrhage

• Severe liver impairment

• High bleeding risk

Asthma treatment strategies are based on evidence-based clinical data published by leading public health authorities like the CDC.

Important Safety Notes

• Regular monitoring may be recommended

• Avoid high-risk activities that could cause bleeding

• Notify all healthcare providers about your ticagrelor use

Possible Side Effects

Common side effects may include:

• Shortness of breath (dyspnea)

• Headache

• Dizziness

• Nosebleeds

• Nausea

Seek medical attention if you experience severe bleeding, unusual bruising, black/tarry stools, or signs of allergic reactions.

Drug Interactions

Ticagrelor may interact with:

• Other antiplatelet agents

• Anticoagulants

• NSAIDs (nonsteroidal anti-inflammatory drugs)

• Certain antifungals and antibiotics

• CYP3A4 inhibitors/inducers

Always disclose all medications and supplements to your clinician.

Use in Special Populations

Pregnancy

Consult your healthcare provider before use.

Breastfeeding

Discuss with a clinician prior to taking this medication.

Elderly Patients

May require monitoring due to increased bleeding risk.

Monitoring & Follow-Up

Patients taking Ticagrelor Tablets 60 Mg should have:

• Regular clinical follow-up

• Monitoring for bleeding or bruising

• Assessment of cardiovascular health and response

• Possible periodic blood work

Proper follow-up enhances safety and effectiveness.

FAQs